Edreese H. Alsharaeh

Herein, we report a facile preparation method for mechanically robust and thermally enhanced sand‐polyacrylamide (PAM)‐2D‐nanofillers composite hydrogels and their application in water shutoff. To prepare the sample, 4 wt% of aqueous PAM solution is mixed with organic cross‐linkers of hydroquinone (HQ) and hexamethylenetetramine (HMT) in a 1:1 weight ratio and aqueous potassium chloride (KCl) solution and with a specific amount of 2D‐nanofillers such as commercial graphene (CG) nanosheets or boron nitride nanoparticles (BN NPs). A specific amount of the above solution is added to sand, well mixed, and subsequently cured at 150°C for 8 h. The prepared composite hydrogels were characterized by Fourier‐transform infrared spectroscopy (FT‐IR) for chemical composition and X‐ray diffraction (XRD) for successful hydrogel coating onto the sand particles. Thermal stabilities of the samples have been evaluated by differential scanning calorimetry (DSC). Mechanical properties (storage modulus [ G ′]; loss modulus [ G ″]; gel strength ( G ′/ G ″); and damping factor [ G ″/ G ′]) of the samples were determined using dynamic mechanical analyses. The thermal stability of the samples has reached as high as 193.4°C, while the gel strength is found to be a maximum of 16.2. The water swelling ratio for the composite hydrogel has reached a maximum of 1100% within 1 h.

Dendritic mesoporous organosilica nanoparticles (DMON) are a new class of biodegradable nanoparticles suitable for biomolecule delivery. We studied the photochemical internalization (PCI) and photodynamic therapy (PDT) of DMON to investigate new ways for DMON to escape from the endosomes-lysosomes and deliver biomolecules into the cytoplasm of cells. We added photosensitizers in the framework of DMON and found that DMON were loaded with siRNA or FVIII factor protein. We made four formulations with four different photosensitizers. The photosensitizers allowed us to perform imaging of DMON in cancer cells, but the presence of the tetrasulfide bond in the framework of DMON quenched the formation of singlet oxygen. Fortunately, one formulation allowed us to efficiently deliver proapoptotic siRNA in MCF-7 cancer cells leading to 31% of cancer cell death, without irradiation. As for FVIII protein, it was loaded in two formulations with drug-loading capacities (DLC) up to 25%. In conclusion, DMON are versatile nanoparticles capable of loading siRNA and delivering it into cancer cells, and also loading FVIII protein with good DLC. Due to the presence of tetrasulfide, it was not possible to perform PDT or PCI.